Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OYST | AZN | AMGN | GILD | BMY |
| Company | Oyster Point Pharma Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 11.16 | 170.32 | 379.75 | 130.02 | 62.69 |
| High | 11.20 | 171.89 | 385.13 | 130.67 | 65.22 |
| Low | 11.12 | 169.85 | 378.22 | 128.28 | 62.23 |
| Latest | 11.17 | 170.49 | 384.95 | 129.76 | 64.24 |
| Change | +0.02 | -2.81 | -2.69 | -2.97 | +1.14 |
| % Change | +0.18% | -1.62% | -0.69% | -2.24% | +1.81% |
| Volume | 2,088,200 | 1,396,945 | 983,425 | 2,658,392 | 9,978,093 |
| 20-Day Average Volume | 306,230 | 2,880,349 | 2,270,423 | 6,456,733 | 10,367,408 |
| Previous Close | 11.15 | 173.30 | 387.64 | 132.73 | 63.10 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.13 | 174.30 | 370.05 | 132.15 | 60.06 |
| 20-Day Raw Stochastic | 76.47% | 22.07% | 69.34% | 24.59% | 90.71% |
| 20-Day Relative Strength | 66.58 | 44.78 | 62.53 | 48.83 | 64.81 |
| Weighted Alpha | -44.20 | +6.04 | +31.25 | +10.36 | +45.43 |
| Today's Opinion | 100% Buy | 88% Sell | 100% Buy | 24% Sell | 72% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 100% Buy | 8% Buy | 72% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 56% Buy | 56% Sell | 32% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 12/22/22 | +1.74% since 07/23/26 | +3.50% since 07/23/26 | -0.70% since 07/23/26 | +4.64% since 07/23/26 |
| Low | 11.04 on 12/23/22 | 167.79 on 07/27/26 | 372.16 on 07/24/26 | 128.28 on 07/30/26 | 61.60 on 07/24/26 |
| High | 11.20 on 12/30/22 | 175.04 on 07/29/26 | 398.00 on 07/28/26 | 136.26 on 07/28/26 | 65.18 on 07/30/26 |
| 1-Month | |||||
| %Chg | -0.09% since 11/30/22 | -9.71% since 06/30/26 | +6.18% since 06/30/26 | +2.85% since 06/30/26 | +11.71% since 06/30/26 |
| Low | 11.04 on 12/23/22 | 164.06 on 07/20/26 | 353.95 on 07/15/26 | 125.13 on 07/01/26 | 56.30 on 07/01/26 |
| High | 11.25 on 12/01/22 | 196.41 on 07/02/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 65.18 on 07/30/26 |
| 3-Month | |||||
| %Chg | +98.75% since 09/30/22 | -8.63% since 04/30/26 | +11.05% since 04/30/26 | -0.69% since 04/30/26 | +6.23% since 04/30/26 |
| Low | 5.17 on 10/03/22 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 11.83 on 11/07/22 | 196.41 on 07/02/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 65.18 on 07/30/26 |
| 6-Month | |||||
| %Chg | +157.97% since 06/30/22 | -7.73% since 01/30/26 | +12.46% since 01/30/26 | -8.46% since 01/30/26 | +16.92% since 01/30/26 |
| Low | 4.20 on 07/07/22 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 11.83 on 11/07/22 | 212.71 on 02/18/26 | 398.00 on 07/28/26 | 157.29 on 02/11/26 | 65.18 on 07/30/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 299,847 | 268,772,352 | 209,212,416 | 164,793,568 | 128,854,680 |
| Shares Outstanding, K | 26,844 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 24,540,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -100,660,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 5,590,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -36,750,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.35 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.37 on 11/10/22 | 2.63 on 07/27/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 02/23/23 | 11/05/26 | 08/04/26 | 08/04/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.76 | 17.79 | 16.05 | 10.73 |